Chen L, Magliano DJ, Zimmet PZ: The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol. 2012, 8: 228-236.
Article
CAS
Google Scholar
Nathan DM: Navigating the choices for diabetes prevention. N Engl J Med. 2010, 362: 1533-1535. 10.1056/NEJMe1002322.
Article
CAS
PubMed
Google Scholar
Allen DB: TODAY–a stark glimpse of tomorrow. N Engl J Med. 2012, 366: 2315-2316. 10.1056/NEJMe1204710.
Article
CAS
PubMed
Google Scholar
Polonsky KS: The past 200 years in diabetes. N Engl J Med. 2012, 367: 1332-1340. 10.1056/NEJMra1110560.
Article
CAS
PubMed
Google Scholar
Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M: National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011, 378: 31-40. 10.1016/S0140-6736(11)60679-X.
Article
CAS
PubMed
Google Scholar
The UK, Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998, 352: 837-853.
Article
Google Scholar
The UK, Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998, 352: 854-865.
Article
Google Scholar
American Diabetes Association: Standards of Medical Care in Diabetes—2014. Diabetes Care. 2014, 37: S14-S80.
Article
Google Scholar
Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, Erqou S, Sattar N: Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009, 373: 1765-1772. 10.1016/S0140-6736(09)60697-8.
Article
CAS
PubMed
Google Scholar
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS: Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Circulation. 2009, 119: 351-357. 10.1161/CIRCULATIONAHA.108.191305.
Article
PubMed
Google Scholar
Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassai B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C: Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ. 2011, 343: d4169-10.1136/bmj.d4169.
Article
PubMed
PubMed Central
Google Scholar
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000, 321: 405-412. 10.1136/bmj.321.7258.405.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010, 375: 2215-2222.
Article
CAS
PubMed
Google Scholar
Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1999, 100: 1134-1146. 10.1161/01.CIR.100.10.1134.
Article
CAS
PubMed
Google Scholar
Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M: Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia. Diabetes Care. 2008, 31 (Suppl 2): S155-S160.
Article
CAS
PubMed
Google Scholar
Conus F, Rabasa-Lhoret R, Peronnet F: Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab. 2007, 32: 4-12. 10.1139/h06-092.
Article
PubMed
Google Scholar
Rodríguez A, Ciprés L, Tofé S, Polavieja P, Reviriego J: Clinical evaluation of combined therapy for type 2 diabetes. Curr Med Res Opin. 2010, 26: 1171-1183. 10.1185/03007991003733239.
Article
PubMed
Google Scholar
Rodríguez A, Calle A, Vázquez L, Chacón F, Polavieja P, Reviriego J, CADiNI Study Group: Blood glucose control and quality of health care in non-insulin-treated patients with Type 2 diabetes in Spain: a retrospective and cross-sectional observational study. Diabet Med. 2011, 28: 731-740. 10.1111/j.1464-5491.2011.03258.x.
Article
PubMed
PubMed Central
Google Scholar
Rodríguez Bernardino A, García Polavieja P, Reviriego Fernández J, Serrano Ríos M: [Prevalence of metabolic syndrome and consistency in its diagnosis in type 2 diabetic patients in Spain]. Endocrinol Nutr. 2010, 57: 60-70. 10.1016/j.endonu.2009.12.002.
Article
PubMed
Google Scholar
Dilla T, Valladares A, Nicolay C, Salvador J, Reviriego J, Costi M: Healthcare costs associated with change in body mass index in patients with type 2 diabetes mellitus in Spain: the ECOBIM study. Appl Health Econ Health Policy. 2012, 10: 417-430. 10.1007/BF03261876.
Article
PubMed
PubMed Central
Google Scholar
Costi M, Dilla T, Reviriego J, Castell C, Goday A: Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain. Acta Diabetol. 2010, 47: 169-175. 10.1007/s00592-009-0158-8.
Article
PubMed
Google Scholar
Gomis R, Artola S, Conthe P, Vidal J, Casamor R, Font B, Investigadores del Grupo de Estudio OBEDIA: Prevalence of type 2 diabetes mellitus in overweight or obese patients outpatients in Spain. OBEDIA Study. Med Clin (Barc). 2014, 142: 485-492. 10.1016/j.medcli.2013.03.013.
Article
Google Scholar
Logue J, Walker JJ, Colhoun HM, Leese GP, Lindsay RS, McKnight JA, Morris AD, Pearson DW, Petrie JR, Philip S, Wild SH, Sattar N, Scottish Diabetes Research Network Epidemiology Group: Do men develop type 2 diabetes at lower body mass indices than women?. Diabetologia. 2011, 54: 3003-3006. 10.1007/s00125-011-2313-3.
Article
CAS
PubMed
PubMed Central
Google Scholar
Mata-Cases M, Mauricio D, Vinagre I, Morros R, Hermosilla E, Fina F, Rosell-Murphy M, Castell C, Franch-Nadal J, Bolíbar B: Treatment of hyperglycaemia in type 2 diabetic patients in a primary care population database in a Mediterranean area (Catalonia, Spain). J Diabetes Metab. 2014, 5: 2-http://dx.doi.org/10.4172/2155-6156.1000338,
Google Scholar
Aranceta-Bartrina J, Serra-Majem L, Foz-Sala M, Moreno-Esteban B: Prevalencia de obesidad en España. Med Clin (Barc). 2005, 125: 460-466. 10.1157/13079612.
Article
Google Scholar
Casanueva FF, Moreno B, Rodriguez-Azeredo R, Massien C, Conthe P, Formiguera X, Barrios V, Balkau B: Relationship of abdominal obesity with cardiovascular disease, diabetes and hyperlipidaemia in Spain. Clin Endocrinol (Oxf). 2010, 73: 35-40.
Google Scholar
Aranceta J, Perez Rodrigo C, Serra Majem L, Ribas Barba L, Quiles Izquierdo J, Vioque J, Tur Mari J, Mataix Verdu J, Llopis Gonzalez J, Tojo R, Foz Sala M: Prevalencia de la obesidad en España: resultados del estudio SEEDO 2000. Med Clin (Barc). 2003, 120: 608-612. 10.1016/S0025-7753(03)73787-7.
Article
Google Scholar
Gutierrez-Fisac JL, Guallar-Castillon P, Leon-Munoz LM, Graciani A, Banegas JR, Rodriguez-Artalejo F: Prevalence of general and abdominal obesity in the adult population of Spain, 2008–2010: the ENRICA study. Obes Rev. 2012, 13: 388-392. 10.1111/j.1467-789X.2011.00964.x.
Article
CAS
PubMed
Google Scholar
Pinhas-Hamiel O, Zeitler P: The global spread of type 2 diabetes mellitus in children and adolescents. J Pediatr. 2005, 146: 693-700. 10.1016/j.jpeds.2004.12.042.
Article
PubMed
Google Scholar
Power C, Thomas C: Changes in BMI, duration of overweight and obesity, and glucose metabolism: 45 years of follow-up of a birth cohort. Diabetes Care. 2011, 34: 1986-1991. 10.2337/dc10-1482.
Article
PubMed
PubMed Central
Google Scholar
Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H: Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr. 2006, 84: 427-433.
CAS
PubMed
Google Scholar
Soriguer F, Goday A, Bosch-Comas A, Bordiu E, Calle-Pascual A, Carmena R, Casamitjana R, Castano L, Castell C, Catala M, Delgado E, Franch J, Gaztambide S, Girbes J, Gomis R, Gutierrez G, Lopez-Alba A, Martinez-Larrad MT, Menendez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martinez G, Serrano-Rios M, Valdes S, Vazquez JA, Vendrell J: Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study. Diabetologia. 2012, 55: 88-93. 10.1007/s00125-011-2336-9.
Article
CAS
PubMed
Google Scholar
Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, Srinivasan SR, Daniels SR, Davis PH, Chen W, Sun C, Cheung M, Viikari JS, Dwyer T, Raitakari OT: Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med. 2011, 365: 1876-1885. 10.1056/NEJMoa1010112.
Article
CAS
PubMed
Google Scholar
Capewell S, Buchan I: Why have sustained increases in obesity and type 2 diabetes not offset declines in cardiovascular mortality over recent decades in Western countries?. Nutr Metab Cardiovasc Dis. 2012, 22: 307-311. 10.1016/j.numecd.2012.01.005.
Article
PubMed
Google Scholar
Preston SH: Deadweight?–The influence of obesity on longevity. N Engl J Med. 2005, 352: 1135-1137. 10.1056/NEJMe058009.
Article
CAS
PubMed
Google Scholar
Vinagre I, Mata-Cases M, Hermosilla E, Morros R, Fina F, Rosell M, Castell C, Franch-Nadal J, Bolibar B, Mauricio D: Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain). Diabetes Care. 2012, 35: 774-779. 10.2337/dc11-1679.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gerstein HC, Miller ME, Byington RP, Goff DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH, Probstfield JL, Simons-Morton DG, Friedewald WT, Action to Control Cardiovascular Risk in Diabetes Study Group: Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008, 358: 2545-2559.
Article
CAS
PubMed
Google Scholar
Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F, ADVANCE Collaborative Group: Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008, 358: 2560-2572.
Article
CAS
PubMed
Google Scholar
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD, VADT Investigators: Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009, 360: 129-139. 10.1056/NEJMoa0808431.
Article
CAS
PubMed
Google Scholar
Grau M, Elosua R, Cabrera de Leon A, Guembe MJ, Baena-Diez JM, Vega Alonso T, Javier Felix F, Zorrilla B, Rigo F, Lapetra J, Gavrila D, Segura A, Sanz H, Fernandez-Berges D, Fito M, Marrugat J: [Cardiovascular risk factors in Spain in the first decade of the 21st Century, a pooled analysis with individual data from 11 population-based studies: the DARIOS study]. Rev Esp Cardiol. 2011, 64: 295-304. 10.1016/j.recesp.2010.11.005.
Article
PubMed
Google Scholar
Stefan N, Häring HU, Hu FB, Schulze MB: Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications. Lancet Diabetes Endocrinol. 2013, 1: 152-162. 10.1016/S2213-8587(13)70062-7.
Article
PubMed
Google Scholar
Jais A, Einwallner E, Sharif O, Gossens K, Lu TT, Soyal SM, Medgyesi D, Neureiter D, Paier-Pourani J, Dalgaard K, Duvigneau JC, Lindroos-Christensen J, Zapf TC, Amann S, Saluzzo S, Jantscher F, Stiedl P, Todoric J, Martins R, Oberkofler H, Müller S, Hauser-Kronberger C, Kenner L, Casanova E, Sutterlüty-Fall H, Bilban M, Miller K, Kozlov AV, Krempler F, Knapp S, et al: Heme oxygenase-1 drives metaflammation and insulin resistance in mouse and man. Cell. 2014, 158: 25-40. 10.1016/j.cell.2014.04.043.
Article
CAS
PubMed
Google Scholar
Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR, American Diabetes Association: Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012, 35: 1364-1379. 10.2337/dc12-0413.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fagot-Campagna A, Balkau B, Simon D, Ducimetière P, Eschwège E: Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol. 1997, 26: 542-550. 10.1093/ije/26.3.542.
Article
CAS
PubMed
Google Scholar
Tseng CH: Exogenous insulin use and hypertension in adult patients with type 2 diabetes mellitus. Arch Intern Med. 2006, 166: 1184-1189. 10.1001/archinte.166.11.1184.
Article
PubMed
Google Scholar
Phillips CM: Metabolically healthy obesity: Definitions, determinants and clinical implications. Rev Endocr Metab Disord. 2013, 14: 219-227. 10.1007/s11154-013-9252-x.
Article
CAS
PubMed
Google Scholar